Effect of CHRNA1 and ORM1 Gene Polymorphism on Neuromuscular Blockade of Vecuronium

段宏伟,吴海星,吴一鸣,宋颖,高鸿,马端
DOI: https://doi.org/10.3969/j.issn.1671-7171.2017.12.001
2017-01-01
Abstract:[Objective] To investigate the effect of CHRNA1 and ORM1 gene polymorphism on neuromuscular blockade of vecuronium.[Methods] A total of 114 women patients with (ASA Ⅰ ~ Ⅱ grade,18-65 years of age,who underwent breast lump removal under general anesthesia) were selected.The peripheral venous blood was collected 5 mL before operation and directly sequenced by 3730 XL DNA sequencer(Applied Biosystems,USA).2ED95 (0.1 mg / kg) of vecuronium bromide was administered during anesthesia induction.The muscle relaxation monitoring was carried out by the TOF-Watch accelerometer.The contractile response of adductor pollicis muscle was monitored by train of four(TOF)stimulation.The onset time,time of action,time of action in vivo,recovery index and time from TOF ratio to 25% were observed.The 90 % confidence interval according to the neuromuscular blockade monitoring index was included in the standard through which 12 were selected of the 107 patients.CHRNA1 total exons,rs16862847 and ORM1 (A113G)were sequenced.[Results]The total exon of CHRNA1 gene,rs16862847SNP site and ORM1 A113G sequencing in 12 patients showed no mutation was found in the total exon of CHRNA1 gene and rs16862847.ORM1 found 7 cases of A113G heterozygote mutation (ORM1 * F/* S),5 undiscovered mutations (ORM1 * F /* F).[Conclusion] ORM1 A113G gene polymorphism may affect the neuromuscular blockade of vecuronium to a certain extent,yet the possible mechanisms need to be further studied.
What problem does this paper attempt to address?